Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Autolus Therapeutics PLC Sponsored ADR (AUTL) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$26.22M |
|
$-71.60M |
|
$24.57M |
|
$1.65M |
|
$85.73M |
|
$-59.51M |
|
$-11.22M |
|
$-70.73M |
|
$-70.73M |
|
$-71.60M |
|
$-71.60M |
|
$-71.60M |
|
$-71.60M |
|
$-59.51M |
|
$-56.81M |
|
266.14M |
|
266.14M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$368.83M |
|
$61.91M |
|
$158.23M |
|
$527.07M |
|
$63.60M |
|
-- |
|
$354.64M |
|
$418.24M |
|
$108.83M |
|
$89.85M |
|
$108.83M |
|
266.16M |
|
| Cash Flow Statement Financials | |
$-65.32M |
|
$96.15M |
|
$-2.06M |
|
$105.64M |
|
$132.42M |
|
$26.78M |
|
$3.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.80 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
6.29% |
|
-226.99% |
|
-226.99% |
|
-- |
|
-269.80% |
|
-273.09% |
|
$-68.00M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.74 |
|
0.95 |
|
94.96 |
|
-65.79% |
|
-79.69% |
|
-13.58% |
|
-65.79% |
|
$0.41 |
|
$-0.26 |
|
$-0.25 |
|